Long Term Care Journal
Thursday, September 13, 2018
FDA approves new kind of treatment for hairy cell leukemia - FDA Press Releases
FDA approves Lumoxiti (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia
from Food and Drug Administration--Press Releases https://ift.tt/2Ok6Qyu
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment